Shares on Issue SOI

OncoSil Medical Ltd – Full Securities Register (Post 400:1 Consolidation)

	Item	Security Code	Description	Pre-Consolidation Qty	Post-Consolidation Qty	Strike Price (Pre)	Strike Price (Post)
1	1a	–	Ordinary Shares – Pre Raise	4,606,580,162	11,516,450	–	–
2	1b	–	Ordinary Shares – Issued in $6.7M Raise @ $0.003	2,233,333,333	5,583,333	–	–
3	1c	–	Ordinary Shares – Issued in $2M SPP @ $0.003	666,666,667	1,666,667	–	–
4	1	OSL	Total Ordinary Shares on Issue	7,506,580,162	18,766,450	–	–
5	2	NEW-PLACEMENT	Option (Placement, Exp. 31-Jul-2027)	2,333,333,333	5,833,333	$0.003	$1.200
6	3	NEW-SPP	Option (SPP, Exp. 31-Jul-2027)	666,666,667	1,666,667	$0.003	$1.200
7	4	NEW-ADVISER	Option (Adviser, Exp. 31-Jul-2027)	75,065,822	187,665	$0.003	$1.200
8	—	–	Subtotal – $1.20 Options (Placement, SPP, Adviser)	3,075,065,822	7,687,665	–	–
9	—	–	Grand Total – Ordinary + $1.20 Options	10,581,645,984 - FULLY DILUTED IF ALL Options above converted above $1.20	26,454,115	–	–

Dilution Factor

If the original shareholder base was equal to11,516,450 shares(post-consolidation equivalent of 4.6B), and the fully diluted capital is now 26,454,115 shares, then:

Dilution Factor=26,454,11511,516,450≈2.30×Dilution Factor=11,516,45026,454,115≈2.30×

✅ Interpretation

Your original percentage ownership is now:

• 1 / 2.30 ≈ 43.5%, or

• You’ve been diluted by a factor of~2.3× Fully diluted scenario ( new options at $1.2 strike )

Market Cap by Share Price (AUD)

	Share Price (AUD)	Market Cap (AUD)
1	$1.00	$26,454,115
2	$2.00	$52,908,230
3	$3.00	$79,362,345
4	$4.00	$105,816,460
5	$5.00	$132,270,575
6	$6.00	$158,724,690
7	$7.00	$185,178,805
8	$8.00	$211,632,920
9	$9.00	$238,087,035
10	$10.00	$264,541,150
11	$11.00	$290,995,265
12	$12.00	$317,449,380
13	$13.00	$343,903,495
14	$14.00	$370,357,610
15	$15.00	$396,811,725
16	$16.00	$423,265,840
17	$17.00	$449,719,955
18	$18.00	$476,174,070
19	$19.00	$502,628,185
20	$20.00	$529,082,300

DISCLAIMER: Do not rely on these figures, do your own calculations and consult your fin. adviser if in doubt.